Break the chain

1. At a Glance

• Leprosy (Hansen's disease) is still being transmitted in parts of India, even though WHO declared in 2005 that India had "eliminated" it as a public health problem [1].
• In this context, "Break the chain" means moving from lowering prevalence to stopping transmission. The National Strategic Plan & Roadmap for Leprosy 2023–27 has adopted that goal [1][2][3].
• For UPSC, the topic matters for three reasons: neglected tropical diseases (NTDs), SDG 3.3, the difference between "elimination" and "eradication", and why a vertical health programme can lose ground once it is merged into the general health system [1][2].

2. Why in the News

• The Hindu editorial "Break the chain" (7 Oct 2026, p.10, Chennai edition) argues that India must focus on cutting leprosy transmission [1].
• The 2025–26 National Leprosy Elimination Programme report says only 148 districts have achieved "interruption of transmission" (field verification pending). The projected figure was 300 [1].
• The 2027 zero-transmission deadline is now close, which raises the question of whether India can meet the NSP target [1][2].

3. Background & Evolution

• 2005: National prevalence fell below 1 case per 10,000 people. WHO then declared that India had "eliminated [leprosy] as a public health problem" [1].
• After 2005: The government became complacent. Leprosy surveillance was folded into the general health system [1].
• MDT effect: Shorter multi-drug therapy regimens meant patients stayed on the register for less time. Recorded prevalence fell, but transmission continued [1].
• Early 2010s: Disability caused by leprosy started rising again, which led to door-to-door screening [1].
• 30 Jan 2023: The National Strategic Plan (NSP) & Roadmap for Leprosy (2023–27) was launched. Its aim is zero transmission by 2027 [2][3].
• Oct 2025: PIB released the backgrounder "Leprosy in India: The Road to a Disease-Free Future" [2][5].

4. Core Static Facts

Item	Fact
Programme	National Leprosy Eradication/Elimination Programme (NLEP). Both names appear in sources [1][3].
Strategy document	NSP & Roadmap for Leprosy 2023–2027 [2][3]
Launch date	30 January 2023 [2][3]
Headline target	Zero transmission by 2027, three years ahead of the SDG 3.3 deadline (2030) [2][3]
"Interruption of transmission" (district level)	Zero new child cases for at least 5 consecutive years [2][3]
"Elimination as a disease" (district level)	After interruption is achieved, zero new cases for at least 3 consecutive years [2][3]
"Elimination as a public health problem" (older WHO yardstick)	Prevalence below 1 per 10,000 population. India reached this by 2005 [1]
Free services under NLEP	Diagnosis, MDT treatment, and post-exposure prophylaxis (PEP) with single-dose rifampicin (SDR) for healthy contacts [2][3]
Global alignment	Global Leprosy Strategy 2021–2030 and the WHO NTD Roadmap 2021–2030 [2][3]
High-burden states	Chhattisgarh, Jharkhand, Odisha, Maharashtra [1]
2025–26 screening	More than 70 crore people screened in highly endemic areas, with 24,367 cases detected [1]
Child cases	India accounted for about 46% of all child cases reported in 2025 (the editorial treats this as a global share) [1]

5. Multi-Dimensional Analysis

Social

• Leprosy causes deformity, and grade-2 disability drives stigma and loss of livelihood. This is why post-treatment surveillance and "care after cure" are part of the NSP [1][2].
• New child cases indicate recent community transmission, which is why the NSP uses them to measure interruption [2][3].
• The burden falls mostly on states with large tribal and poor populations: Chhattisgarh, Jharkhand and Odisha [1].

Governance / Administrative

• The "elimination" declaration of 2005 led to complacency. Merging the vertical programme into the general health system weakened surveillance [1].
• Districts certified so far are only about half the target (148 against 300), and those certifications still await field verification [1].
• The NSP calls for multi-disease service integration while still keeping leprosy expertise in place [2][3].
• ASHA workers do frontline active case detection [1].

Scientific / Technological

• Shortened MDT regimens reduce how long a case appears in the register. Low prevalence therefore does not prove that transmission has stopped [1].
• The main preventive tool for contacts is SDR-PEP. The NSP also introduces new treatment regimens [2][3].

Ethical

• Counting a disease as "eliminated" because it went below a statistical threshold, while real people are still being infected, raises a question of honesty in public-health reporting [1].

Global / Strategic

• India's progress largely decides whether the world meets its leprosy targets, given the 46% share of child cases [1].
• India's 2027 target is set three years ahead of the SDG 3.3 deadline [2][3].

6. Recent Developments (last 12–18 months)

• Oct 2025: PIB released the backgrounder "Leprosy in India: The Road to a Disease-Free Future" [2][5].
• 2025: India accounted for about 46% of child cases reported worldwide [1].
• 2025–26: More than 70 crore people were screened in endemic areas and 24,367 cases were detected [1].
• 2025–26 NLEP report: 148 districts have achieved interruption of transmission (pending verification), against 300 projected [1].
• 7 Oct 2026: The Hindu editorial "Break the chain" was published [1].

7. Prelims Hooks

• The NSP & Roadmap for Leprosy 2023–27 was launched on 30 January 2023 [2][3].
• NSP target: zero transmission of leprosy by 2027 [2][3].
• The 2027 target is three years ahead of SDG 3.3 [2][3].
• District-level interruption of transmission = no new child case for at least 5 consecutive years [2][3].
• District-level elimination as a disease = no new case for at least 3 consecutive years after interruption [2][3].
• Post-exposure prophylaxis for healthy contacts uses single-dose rifampicin (SDR) [2][3].
• India reached prevalence below 1 per 10,000 by 2005, and WHO declared elimination as a public health problem [1].
• The NSP aligns with the Global Leprosy Strategy 2021–2030 and the WHO NTD Roadmap 2021–2030 [2][3].
• High-burden states: Chhattisgarh, Jharkhand, Odisha, Maharashtra [1].
• India accounted for about 46% of child leprosy cases reported in 2025 [1].
• 148 districts have achieved interruption of transmission, against 300 projected (2025–26) [1].
• In 2025–26, 24,367 cases were detected from more than 70 crore people screened in endemic areas [1].

8. Why 148 'Clean' Districts May Not Really Be Clean

• The test counts children found, not children infected
• A district is said to have stopped transmission (stopped the disease spreading) when it records no new child case for 5 years in a row [2][3].
• A case is only recorded if a health worker finds it. If nobody is searching, the district will show zero child cases even when children are being infected.

• After 2005, leprosy surveillance (the routine search for and tracking of cases) was merged into general health services and became weaker [1]. So in some districts, 'zero cases' may only mean 'zero cases looked for'.

• There are many hidden cases waiting to be found

• Screening in endemic areas in 2025–26 found 24,367 cases [1]. Endemic areas are places where the disease is regularly present.
• These people were not already on any register. They were found only because teams went from door to door.

• The government had to start a separate drive, the Leprosy Case Detection Campaign (LCDC), just to find hidden cases [6]. That shows the normal system was missing them.

• The 148 figure has not been checked yet

• All 148 districts are still waiting for field verification, meaning a check on the ground [1].
• Until that check is done, 148 is a figure the districts reported themselves, not a confirmed result. And it is already only half of the 300 that were projected [1].

9. Searching Harder Will Make the Numbers Look Worse First

• A good search raises the case count
• When screening gets better, recorded cases go up, because hidden cases come to light. The 2025–26 drive is an example [1].

• A rising number in a district can therefore be a sign of good work. It need not mean the disease is spreading faster.

• The 2027 deadline pushes districts the other way

• The target is zero transmission by 2027 [2][3]. A district earns that status by reporting no child cases [2][3].
• A district that searches hard will find child cases, and its 5-year count starts again from zero.

• So the deadline can make a district look worse for working harder, and better for searching less.

• India has made this mistake before

• In 2005, India crossed a statistical line: fewer than 1 case per 10,000 people [1].
• Shorter multi-drug therapy (MDT) meant patients stayed on the register for less time. Prevalence (cases on the books at one moment) fell, but the disease kept spreading [1].
• A target of zero child cases can repeat the same error if nobody checks how hard each district is searching.

10. Was Declaring 'Elimination' in 2005 a Mistake?

• The strongest case for the 2005 decision
• 'Below 1 per 10,000' was WHO's official yardstick (measure), so India did not invent a convenient number [1].
• Bringing prevalence that low needed free MDT on a very large scale. That was a real public-health achievement.

• Global targets also work this way. Countries meet milestones step by step, and India's present 2027 goal sits on top of earlier goals of the same kind [2][3].

• What this argument gets right

• Meeting the target was not dishonest. The threshold was real, and huge numbers of patients were cured.

• Where it fails

• The mistake came after the target was met. India treated a halfway milestone as the end of the job [1].
• The vertical programme (a separate programme with its own staff and money for one disease) was merged into general health services, and surveillance became weaker [1].

• In the early 2010s, disability caused by leprosy started rising again [1]. A patient usually becomes disabled only when the disease is diagnosed late. Rising disability therefore showed that the system had stopped finding cases early.

• Lesson for Mains: the problem was not the target itself. It was cutting back the surveillance teams once the target was met.

11. Stigma Hides Patients, and Hidden Patients Spread Leprosy

• The law itself has treated leprosy as a reason to exclude people
• Health Ministry figures listed 108 laws that discriminated against people affected by leprosy: 3 Union laws and 105 State laws [8].

• In 2015, Law Commission Report No. 256 recommended repealing the Lepers Act, 1898 and removing the discriminatory provisions in personal laws [7].

• How stigma keeps the disease spreading

• When a diagnosis can cost someone their job, their marriage or their place in the community, people with early symptoms avoid the clinic.
• Every month a patient stays untreated, the people living with them remain exposed.

• The patient also comes in late, often after disability has set in. Grade-2 disability (visible deformity) then adds to the stigma [1][2].

• Why this matters for 'break the chain'

• Single-dose rifampicin post-exposure prophylaxis (SDR-PEP, one dose of a medicine that protects healthy contacts) can be given only to contacts who have been identified [2][3].
• If a family hides a case, its contacts are never traced, and the prevention tool never reaches them. Stigma is therefore a medical problem, not only a social one.

12. What Must Be Done Before the 2027 Deadline

• The Central Leprosy Division should get the 148 districts checked by outside teams before certifying them
• Today, 148 districts have reported interruption, but none has been verified on the ground [1].

• The checking teams should come from outside the district. Otherwise, the district grades its own homework.

• States should keep active case search running even in districts that report zero

• The LCDC model of searching for hidden cases [6] should continue throughout the 5-year counting period, not stop once the count begins.

• Districts should report how many people they screened next to how many cases they found. Then a 'zero' can be judged against the effort behind it.

• NLEP should give SDR-PEP to every contact of every new case

• SDR-PEP is already provided free under NLEP [2][3]. What limits it is how many contacts are actually traced. Each untraced contact is a link in the chain that stays unbroken.

• Keep leprosy experts inside the merged system

• The NSP already asks for leprosy expertise to be kept within multi-disease services [2][3].

• The lesson of 2005 is that merging programmes without protecting this expertise led directly to weak surveillance [1].

• Parliament and State legislatures should act on Law Commission Report No. 256

• The Commission drafted a model law, the Eliminating Discrimination Against Persons Affected by Leprosy (EDPAL) Bill, 2015. It guarantees equal treatment and access to healthcare, housing, education and jobs [7].
• The Union Health Minister wrote to the Law and Social Justice Ministries asking for the 108 discriminatory laws to be amended [8]. Finishing this work removes one reason patients hide.

13. Anchors for Answers

• Data: 148 districts have reported interruption of transmission, against 300 projected, with all 148 still awaiting field verification (NLEP 2025–26) [1]
• Data: 24,367 cases were found among more than 70 crore people screened in endemic areas in 2025–26. This shows how many cases sit hidden outside the registers [1]
• Data: India accounted for about 46% of child leprosy cases reported in 2025 [1]
• Report/Committee: Law Commission of India, Report No. 256, Eliminating Discrimination Against Persons Affected by Leprosy (2015). It recommended repealing the Lepers Act, 1898 and drafted the EDPAL Bill, 2015 [7]
• Law/Case: 108 discriminatory laws against people affected by leprosy (3 Union, 105 State) were flagged by the Union Health Ministry for amendment [8]
• Scheme: Leprosy Case Detection Campaign (LCDC), the Central Leprosy Division's drive to find hidden cases [6]. Also SDR-PEP for contacts under the NSP 2023–27 [2][3]

14. Mains Relevance

• GS-II: Issues relating to the development and management of the social sector and services relating to health; welfare of vulnerable sections.
• GS-III (secondary): Science and technology (drug regimens, chemoprophylaxis).
• GS-IV (secondary): Ethics in public reporting and in dealing with stigma.
• Possible question stems: 1. India achieved the 'elimination' of leprosy as a public health problem in 2005, yet transmission persists. Critically examine the gaps and suggest measures to achieve the 2027 zero-transmission goal. 2. Integration of vertical disease programmes into general health systems can be a double-edged sword. Discuss with reference to leprosy control in India. 3. New child cases are the most sensitive indicator of ongoing leprosy transmission. Explain, and evaluate the NSP 2023–27's district-level approach.

15. Related Topics to Study Next

• NTDs and the WHO NTD Roadmap 2021–2030: leprosy is an NTD, and the NSP is aligned to this roadmap [2][3].
• SDG 3.3: the reference deadline for India's 2027 target [2][3].
• Elimination of TB by 2025 and kala-azar / lymphatic filariasis campaigns: comparable disease-elimination programmes, also with an "elimination vs eradication" angle.
• Role of ASHA workers / NHM: they carry out frontline case detection [1].
• Antimicrobial resistance: relevant because MDT and SDR are used at scale.
• Discriminatory laws against people affected by leprosy (Law Commission / SC references): the social-stigma dimension.
• Tribal health: most high-burden districts are in tribal-majority states [1].

16. NCERT Concepts to Revise

• Screening (Economy): The note's door-to-door screening and contact screening aim to find hidden leprosy cases that registers miss.
• Governance (Polity): The 2005 elimination claim and later merging of the programme into general health services show governance lapses.
• Economic development (Economy): Health outcomes like leprosy control are part of development; SDG 3.3 targets well-being beyond income growth.
• Services (Economy): Diagnosis, free treatment and preventive medicine are health services, delivered by frontline workers such as ASHAs.

17. Common Errors / Trap Areas

• Elimination is not eradication. India's 2005 "elimination" only meant prevalence below 1 per 10,000, not zero cases [1].
• Getting the thresholds mixed up: interruption of transmission needs 5 years with no child cases. Elimination as a disease needs 3 years with no cases of any age [2][3].
• Wrong target year: the NSP target is 2027. 2030 is the SDG/WHO deadline [2][3].
• Wrong reading of prevalence: a fall in registered prevalence does not mean incidence or transmission has fallen. Shorter MDT shortened the time cases stay on the register [1].
• Programme name: the acronym NLEP appears as both "Eradication" and "Elimination" programme in different sources. Recognise both [1][3].